Lycopene Skin Aging Randomized Trial: What the Evidence Says

Quick Answer

Lycopene Skin Aging Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• At the cellular level, senescent cells exhibit reduced proliferative capacity and cell cycle arrest, accompanied by the production of senescence-associated secretory phenotype (SASP). [Lan Meng (2026); evidence level 3]
• Gut microbiota dysbiosis is closely associated with multiple organ functional decline, immunosenescence, increased chronic inflammation levels, and weakened gut barrier function in the elderly, all of which are "signs of aging". [Lan Meng (2026); evidence level 3]
• A diet rich in phytonutrients found in fruits and vegetables (FV) is critical for optimal health. [Jilcott Pitts Stephanie B. (2025); evidence level 4]
• Diets rich in carotenoids are linked with positive health outcomes, including reductions in the risk of cardiovascular disease and certain cancers. [Jilcott Pitts Stephanie B. (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For lycopene skin aging randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Lan Meng (2026). Gut microbiota and aging: current understanding and future perspectives. DOI: 10.1186/s43556-026-00499-0. PMCID: PMC13294431. PMID: 42343035. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13294431/
• Jilcott Pitts Stephanie B. (2025). Daily intake of a lycopene-rich juice is associated with reductions in inflammatory markers but not increases in skin carotenoids in a pilot study among participants with obesity. DOI: 10.1186/s40795-025-01222-y. PMCID: PMC12838468. PMID: 41420244. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12838468/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.